RGLS
Regulus Therapeutics Inc.
President and CEO Joseph P Hagan sold $48K of Regulus Therapeutics Inc.
Sold$47,966
$1.22Price
39,352Shares
−13%Stake
What RGLS did after the filing
Prices for RGLS after this filing aren't in yet.
Traded Thu, May 16. Filed Thu, May 16, 1:25 PM ET, during the session. Not investment advice.